SEO URLwww.firestrike.ai/deals/35pharma-gsk-acquisition-2026
acquisitionAnnounced · Feb 25, 2026biopharmaceuticalSource · CredibleArticle · Factual
GSK acquires 35Pharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$950M
Target
35Pharma
Acquirer
GSK
Full Acquisition
Status
Announced
GSK agreed to acquire 35Pharma. Reported deal value: $950M. Status: Announced. Sector: biopharmaceutical. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-25. Figures and status may change as filings and press coverage update.
Share on Facebook GSK will acquire 35Pharma lead cardiopulmonary asset, HS235 through this acquisition
Deal timeline
Announced
Feb 25, 2026 · pharmaceutical-technology.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $950M. Figures and status may change as sources update.
Sources: pharmaceutical-technology.com · Primary article · FireStrike proprietary index